Protara Therapeutics Inc (TARA)
Healthcare
Biotechnology
4.00 $
+1.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Protara Therapeutics Inc (TARA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -21 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.4 | 0.1 | -8.7 | -10 | -7.7 | -8.4 | -9.3 | -15 | -12 | -12 | -17 | -21 | -63 | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.4 | |
| 1.6 | 1.4 | 1.5 | 1.2 | 1.1 | 0.9 | 0.9 | 0.8 | 0.9 | 1.0 | 1.0 | 1.4 | 4.4 | |
| 1.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 1.9 | -0.2 | -0.8 | 0.4 | 1.8 | 2.5 | -3.8 | 1.8 | -0.2 | -0.7 | -5.1 | -4.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 22 | 6.4 | 15 | 23 | 2.9 | -29 | 23 | -58 | -48 | -6.5 | -27 | -15 | -96 | |
| 0.0 | 0.0 | – | – | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.1 | -0.1 | 0.1 | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | -0.1 | 42 | 0.0 | 98 | 1.7 | 0.0 | 0.0 | 81 | 1.1 | 82 | |
| 13 | 0.1 | 5.8 | 13 | 37 | -38 | 111 | -71 | -60 | -19 | 37 | -35 | -77 | |
| -9.4 | 0.1 | -8.7 | -10 | -7.7 | -8.4 | -9.3 | -15 | -12 | -12 | -17 | -21 | -63 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.